Safety and Efficacy of Metallic Stents in the Management of Colorectal Obstruction by Stefanidis, Dimitrios et al.
Safety and Efficacy of Metallic Stents in the
Management of Colorectal Obstruction
Dimitrios Stefanidis, MD, PhD, Ken Brown, MD, Hector Nazario, MD, Hector H. Trevino, MD,
Hector Ferral, MD, Charles E. Brady, III, MD, Glenn W. Gross, MD, Darren W. Postoak, MD,
Riaz Chadhury, MD, Dennis L. Rousseau, Jr., MD, PhD, Morton S. Kahlenberg, MD
ABSTRACT
Background: The use of self-expandable metallic stents
in the management of obstructing colorectal cancer has
been described with increasing frequency in the literature.
Our goal was to evaluate the efficacy and associated
morbidity of the use of self-expandable metallic stents to
relieve colorectal obstruction at our institution.
Methods: A retrospective chart review of patients who
underwent colorectal stent placement between December
2001 and December 2003 in a tertiary referral center was
performed.
Results: Stents were placed successfully in 17 of 21 pa-
tients (81%) with colorectal obstruction. Placement was
achieved endoscopically in 13 patients and radiologically
in 4. Ten self-expandable metallic stents were used as a
bridge to surgery, and 7 were used for palliation. The
obstructions were located in the sigmoid colon (11 pa-
tients), the rectosigmoid (3), the splenic flexure, the he-
patic flexure, and the rectum. Malignant obstruction was
noted in 14 patients. One patient with malignancy expe-
rienced a sigmoid perforation, and 2 patients with benign
disease had complications (1 stent migration and 1 re-
obstruction). Stent patency in obstruction secondary to
colonic adenocarcinoma was 100% in our follow-up pe-
riod (range, 5 to 15 months).
Conclusions: The use of stents as a bridge to surgery is
associated with low morbidity, allows for bowel prepara-
tion, and thus avoids the need for a temporary colostomy.
Long-term patency suggests that stents may allow for the
avoidance of an operation in patients with metastatic
disease and further defines their role in the palliation of
malignant obstruction. Further prospective randomized
studies are necessary to fully elucidate the use of stents in
the management of colorectal cancer.
Key Words: Stent, Colorectal obstruction, Colorectal can-
cer, Surgery, Palliation.
INTRODUCTION
Colorectal obstruction poses a difficult problem for the sur-
geon and the patient. The need for emergent surgery in a
patient with an unprepared colon leads to significant mor-
bidity and mortality.1–6 In patients with advanced malignant
disease or with prohibitive operative risk, surgical interven-
tion for colorectal obstruction appears even less appealing.
The need for a less morbid treatment modality has led to the
use of self-expandable metallic stents (SEMS) to relieve colo-
rectal obstruction. Since the first report by Dohmoto in 1991,7
this method has gained rapid popularity. The 2 main indica-
tions for SEMS are as a bridge to surgery or for palliation.8–21
The use of SEMS for treatment of benign colorectal disease in
patients with prohibitive operative risk has also been de-
scribed.22,23 SEMS placement can be achieved by radiological
or endoscopic means.8–14
We report our experience with the use of SEMS in the
management of colorectal obstruction, their efficacy, and
associated morbidity.
METHODS
A retrospective chart review of patients undergoing SEMS
placement for colorectal obstruction between December
2001 and December 2003 at the University of Texas Health
Science Center at San Antonio was performed. Patients
eligible for stent placement had clinical and radiographic
evidence of large bowel obstruction. The on-call surgeon
determined whether patients would be considered for
stent placement on a case-by-case basis. The stent used
was the Wallstent Colonic & Duodenal Endoprosthesis
(Boston Scientific/Microvasive, Natick, MA) in all patients.
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SCIENTIFIC PAPERA covered stent was used in 1 patient. Two teams using 2
different techniques placed the SEMS. The interventional
radiology team placed stents under fluoroscopic guid-
ance, whereas the gastroenterology team used endoscopy
in combination with fluoroscopy. These techniques have
previously been described.8–14 The technique utilized was
based on provider availability and surgeon’s preference.
Postprocedure gastrograffin enemas were obtained to
evaluate the proximal colon, and abdominal x-rays were
performed at 24 hours after stent placement to confirm
colonic decompression. Contraindication to stent place-
ment was the presence of colonic perforation. The Insti-
tutional Review Board of our institution approved this
study, and patient confidentiality has been maintained.
RESULTS
Stent placement was attempted in 21 patients with colo-
rectal obstruction. Technical success was achieved in 17
(81%) patients (Figure 1). The 4 stent placement failures
were due to inability to traverse the area of colonic ob-
struction with a guidewire. These patients underwent re-
section of their primary malignancies along with the cre-
ation of a stoma. The median age of the 17 patients was 61
(range, 49 to 76) years. Twelve patients were male and 5
were female. One patient had 2 stents placed for 2 syn-
chronous obstructing lesions.
Thirteen of 16 patients had successful endoscopic stent
placement by the gastroenterology team, and 4 of 5 pa-
tients had successful fluoroscopic stent placement by the
interventional radiology team. The location of colonic
obstruction was in the sigmoid colon (11 patients), the
rectosigmoid (3 patients), the upper rectum (1 patient),
the splenic flexure (1 patient), and the hepatic flexure (1
patient). Stents were placed as a bridge to surgery in 10
patients and for palliation in 7 patients (Table 1).
The colonic obstruction was due to malignancy in 14 pa-
tients (colonic adenocarcinoma in 13 patients and locally
advanced prostate cancer in 1 patient), benign strictures in 2
patients, and the cause was unknown in 1 patient. The 2
patients with benign conditions included 1 with diverticular
stricture and 1 with anastomotic stricture following colon
resection who had had multiple failed dilations. Both pa-
tients were considered prohibitive operative risks.
Nine of the 10 patients in whom a stent had been placed
as a bridge to surgery received bowel preparation and
hydration and were then brought to the operating room.
Median time to colon resection was 5 days (range, 1 to 12).
All 9 patients were found to have achieved good bowel
Figure 1. (A) Abdominal x-ray showing a patient with colonic
distention due to sigmoid obstruction. (B) Abdominal x-ray of
the same patient showing colonic decompression after sigmoid
stent placement.
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mosis except for 1 patient who required a colostomy. This
patient had a poor nutritional status and locally advanced
disease that resulted in excessive blood loss during resection.
One patient in the bridge to surgery group suffered a sig-
moid perforation at the site of stent placement 4 days after
insertion but did well after emergent surgical intervention
with resection and colostomy formation.
Of the 2 patients with benign strictures, 1 had migration of
a covered stent 3 days after placement, and 1 had occlu-
sion 4 months after placement. The patient with stent
migration refused to have another stent placed and con-
tinued to undergo dilations. The patient with stent occlu-
sion had a colostomy performed without resection of the
diverticular stricture to minimize operative time due to
extensive comorbidities and did well. One patient with
multiple medical comorbidities and sepsis had a colonic
obstruction successfully stented but succumbed to sepsis
4 days later. His death was not related to the stent place-
ment. The cause of his colonic obstruction was considered
to be malignant, but no specimen could be obtained
before his death and the family refused autopsy.
All patients who had their stents placed for palliation of a
malignant colonic obstruction remained free from stent-
related problems in the follow-up period (median, 11
months; range, 5 to 15). One patient died within that
follow-up time with a clinically functioning stent.
DISCUSSION
Ten percent to 25% of patients with colorectal cancer
present with malignant obstruction.1–3,6 Emergency sur-
Table 1.
Case Summary of Patients Who Had Self-Expandable Metallic Stents Placed to Relieve Colonic Obstruction
Patient Age/Sex Method* Location* Obstruction
Cause
Indication Patency
(Days)
Surgery Follow-up
1 72 M Endo SIG Colon cancer Bridge to surgery 1 Resection No complications
2 76 M Endo HF Colon cancer Bridge to surgery 7 Resection No complications
3 56 M Endo SIG Colon cancer Bridge to surgery 12 Resection No complications
4 54 M Endo SIG Colon cancer Bridge to surgery 6 Resection No complications
5 55 M Endo RSG Colon cancer Bridge to surgery 8 Resection No complications
6 61 M Endo SIG Colon cancer Bridge to surgery 6 Resection No complications
7 76 M Endo SIG Colon cancer Bridge to surgery 4 Resection No complications
8 57 M Endo SIG Colon cancer Bridge to surgery 2 Resection &
stoma
No complications
9 56 F Rad SIG Colon cancer Bridge to surgery 4 Resection &
stoma
Sigmoid perforation,
doing well today
10 64 F Rad SIG Colon cancer Bridge to surgery 2 Resection No complications
11 62 M Endo RSG Prostate cancer Palliation 450 None Remained patent
12 66 M Endo REC Metastatic colon
cancer
Palliation 325 None Remained patent
13 57 F Rad RSG Metastatic colon
cancer
Palliation 360 None Remained patent
14 58 M Rad SF Metastatic colon
cancer
Palliation 142 None Died w/patent stent
15 75 M Endo SIG Unknown Palliation 4 None Died due to sepsis
16 49 F Endo SIG Anastomotic stricture Palliation 3 None Stent migration,
continues
on dilations
17 63 F Endo SIG Diverticular stricture Palliation 139 Stoma Stent occlusion
*Endo  endoscopic; Rad  Radiologic; SIG  sigmoid colon; RSG  rectosigmoid; REC  rectum; SF  splenic flexure; HF  hepatic
flexure.
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than elective colon surgery and mortality of 10% to
28%.1–6 This difference in outcome is related to the poor
medical condition of the patients as well as to the unpre-
pared bowel resulting in increased infectious complica-
tions. Effective measures that will allow for the delay of
surgery until patients can be medically optimized and
undergo mechanical preparation of the colon could result
in improved outcomes. In addition, patients who present
with colorectal obstruction and widely metastatic cancer
with poor survival rates and patients who are prohibitive
operative risks would benefit from a minimally invasive
method that would relieve their obstruction and spare
them an unnecessary surgery.
Self-expanding metallic stents have been used widely for
relief of luminal obstructions since their introduction in
clinical practice and have also found application in the
treatment of colonic obstruction. Since the first report by
Dohmoto in 1991,7 multiple studies have appeared in the
literature validating the role of SEMS in the treatment of
colorectal obstruction.8–24
Endoscopic and fluoroscopic placement have been the 2
main techniques used for the deployment of the stents8–14
with successful stent placement ranging between 63% to
100%.21 No available study compares these 2 approaches.
In our study, the 2 techniques performed by 2 different
teams in a nonrandomized fashion appeared to be equally
effective with success rates similar to those previously
reported.
The Wallstent (Boston Scientific/ Microvasive, Natick, MA)
is the most commonly used stent for colorectal obstruc-
tion. It combines excellent radial expansile force with
longitudinal flexibility and can be delivered thru the en-
doscope or over a guidewire due to its small delivery
system.17
In 2 patients, we used colonic stents to relieve colonic
obstruction due to benign disease. The use of stents for
benign diseases of the colon has been described previ-
ously.10,22,23 One of the patients with benign disease ex-
perienced stent migration 3 days after placement, and the
other patient had obstruction of the stent 4 months after
placement. Increased risk for migration has been sug-
gested previously when stents were used for benign dis-
eases, and this has been attributed to the lack of neoplas-
tic ingrowth into the stent that would prevent its
dislodgement.10,16 In addition, the stent that was used in
the patient with migration was covered, and covered
stents have also been found to have higher migration rates
due to the prevention of tissue ingrowth.15,17,21,25
Nine of 10 patients who were treated with stents as a
bridge to surgery received bowel preparation and under-
went resection with primary anastomosis in 8 of 9 cases
with good perioperative outcomes. One patient had a
perforation of her tumor at the distal aspect of the stent
that became clinically apparent 4 days after stent place-
ment. This patient had not been prepped immediately
because of the patient’s desire to delay surgery for several
weeks.
The use of stents as a bridge to surgery has been validated
by studies19,24,26 that have shown less morbidity, less
stoma formation, and shorter hospital stays compared to
emergency surgery for colorectal obstruction. Three stud-
ies have also demonstrated that stent placement is cost-
effective compared to surgery.26–28 Only 1 patient in our
series was noted to have a perforation and this is within
the published range (0% to 15%).16 The risk of perforation
emphasizes the need for close monitoring of these pa-
tients after their procedure. If surgical intervention occurs
in a timely fashion after perforation, good outcomes
should be expected.
Stent placement for palliation of malignant colonic ob-
struction has been described and noted to be an effective
treatment with good patency rates.20,21,26–33 However,
published follow-up is limited because of the poor sur-
vival rates in this patient population and rarely ap-
proaches 1 year. The 100% patency rate observed in this
study with a median follow-up of 1 year is the longest
reported to date. In our series, the low associated mor-
bidity compares favorably with that reported in the pub-
lished literature.20,21,26–33
CONCLUSION
This report supports the use of SEMS in patients who
present with colorectal obstruction secondary to ad-
vanced malignancy (palliative), as a bridge to curative
surgery or for patients who have prohibitive operative
risks. The high technical success rate, the low morbidity
associated with their use, and their excellent patency in
patients with malignant disease make SEMS a very appeal-
ing initial treatment modality for patients who present
with colorectal obstruction.
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